Actively Recruiting
Study of Left Stellate Ganglion Block to Reduce Postoperative Atrial Fibrillation in Patients Having Thoracic Surgery
Led by University of Minnesota · Updated on 2026-08-10
48
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What this Trial Is About
Researchers are evaluating whether adding an ultrasound-guided left sided stellate ganglion block with bupivacaine can reduce the rates of postoperative atrial fibrillation in patients undergoing esophagectomy, pneumonectomy, or lobectomy. This pilot study compares this approach to the standard care to determine its impact on heart rhythm issues after thoracic surgery. Participants will receive either an ultrasound-guided left stellate ganglion block with 5 mL of 0.5% bupivacaine or a similar block with 5 mL of saline as a placebo. The study is randomized and triple-masked, with two groups receiving these interventions during their thoracic surgery. Participants will be monitored for atrial fibrillation, other arrhythmias, and adverse events for up to 168 hours after surgery. The main outcome measured is the occurrence of atrial fibrillation within this period. The study lasts from the surgery day through this 7-day postoperative monitoring phase, with careful assessment of heart rhythm and safety outcomes.
CONDITIONS
Brief Title
Stellate Ganglion Block
Research Team
C
Candace Nelson
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
